Advertisement
Advertisement
TSHA
Taysha Gene Therapies, Inc. Common Stock
6.68
USDSponsored
+0.31
+4.87%
Aug 11, 16:00 UTC -4
Closed
After-Market
6.33
-0.35
-5.27%
Taysha Gene Therapies, Inc. Common Stock Financial Snapshot
| Market Cap | 1.82B |
| Beta | 1.22 |
| Earnings Per Share (EPS) | -0.38 |
| Price-to-Book (P/B) Ratio | 8.89 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 23.10% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -56.07% |
| Current Ratio | 14.04% |
| Free Cash Flow | -40.90M |
Trending Stocks
Advertisement